title: The C-32 triacetyl-L-rhamnose derivative of ascomycin: a potent, orally active macrolactone immunosuppressant.
authors.affiliation: Central Research Division, Pfizer Inc., Groton, Connecticut 06340, USA.
authors.forename: K
authors.initials: K
authors.lastname: Koch
authors.forename: M F
authors.initials: MF
authors.lastname: Newborg
authors.forename: D C
authors.initials: DC
authors.lastname: Hanson
authors.forename: K
authors.initials: K
authors.lastname: Cooper
authors.forename: R M
authors.initials: RM
authors.lastname: Shepard
authors.forename: M L
authors.initials: ML
authors.lastname: Biehl
authors.forename: M S
authors.initials: MS
authors.lastname: Biggers
authors.forename: M
authors.initials: M
authors.lastname: Ramchandani
authors.forename: G
authors.initials: G
authors.lastname: Schulte
authors.forename: J R
authors.initials: JR
authors.lastname: Snyder
mesh_terms: D000284:Administration, Oral; D000818:Animals; D002240:Carbohydrate Sequence; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000737:chemistry* / Q000494:pharmacology; D007783:Lactones / Q000737:chemistry*; D008969:Molecular Sequence Data; D051381:Rats; D012210:Rhamnose / Q000737:chemistry*; D016559:Tacrolimus / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology
chemical_list: D007166:Immunosuppressive Agents; D007783:Lactones; C058028:immunomycin; D012210:Rhamnose; D016559:Tacrolimus